Nearly one-third of ovarian cancer patients were characterized as "lactose absorbers," compared with only 15% of controls. Based on these data, the authors calculate that the risk of ovarian cancer in lactose absorbers is increased 2.51-fold compared with women with normal lactose digestion. The findings provide additional support for "...the role of galactose as an oocyte toxin," Dr. Meloni and others write, and suggest "...that lactose ingestion and lactase persistence may play a role in the pathogenesis of ovarian cancer." Am J Epidemiol 1999;150:183-186.
Ellen
elevine@cooper.cpmc.org
Ellen G. Levine, Ph.D., M.P.H.
Research Director
Psychosocial Oncology
California Pacific Medical Center
2330 Post St., Suite 510
San Francisco, CA 94115
415-885-7491